Because OVOL1 performs a transcription-regulatory function in the nucleus,18 these results suggest that the transcription-regulatory activity of OVOL1 may be impaired in AD skin, subsequently leading to the reduced FLG expression in AD skin. This evidence concerns the gene FLG and Alzheimer disease.